Crossmark

SER-SEPAR recommendations for the management of rheumatoid arthritis-related interstitial lung disease. Part 2: Treatment

Crossref DOI link: https://doi.org/10.1016/j.reumae.2022.03.004

Published Print: 2022-11

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Narváez, Javier http://orcid.org/0000-0002-1614-8064
Díaz del Campo Fontecha, Petra

Brito García, Noé

Bonilla, Gema

Aburto, Myriam

Castellví, Iván

Cano-Jiménez, Esteban

Mena-Vázquez, Natalia

Nieto, M. Asunción

Ortiz, Ana María

Valenzuela, Claudia

Abad Hernández, Miguel Ángel

Castrejón, Isabel

Correyero Plaza, María

Francisco Hernández, Félix Manuel

Hernández Hernández, María Vanesa

Rodríquez Portal, José Antonio
License Information

Text and Data Mining valid from 2022-11-01
More Information

This article is maintained by: Elsevier

Article Title: SER-SEPAR recommendations for the management of rheumatoid arthritis-related interstitial lung disease. Part 2: Treatment

Journal Title: Reumatología Clínica (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.reumae.2022.03.004

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.reuma.2022.03.005

Content Type: article

Copyright: © 2022 Elsevier España, S.L.U. and Sociedad Española de Reumatología y Colegio Mexicano de Reumatología. All rights reserved.